What is it about?

Diabetic cardiomyopathy (heart injury because of diabetes) is one of the most severe complications for diabetic patients. Our present research indicates that mice without S1P receptor 1 on T cells displayed less fibrosis and better recovery from the stress of hyperglycemia in a murine diabetic model. It may shed light on the drug discovery for cardioprotection for diabetic patients. Comparing with the littermate vehicle control mice, these mice without T cell S1P receptor 1 presented cardiac dysfunction and fibrosis at normal glucose levels.

Featured Image

Why is it important?

This article reveals the critical role of T cell S1P receptor 1 (S1P1) in diabetic cardiomyopathy. Deletion of T cell S1P1 protects the heart from diabetic injury. Special deletion of T cell S1P1 may shed light on novel target on cardiac protection in diabetic model.

Perspectives

Special deletion of T cell S1P1 may shed light on novel target on cardiac protection in diabetic model.

Zhuqiu Jin
California Northstate University

Read the Original

This page is a summary of: Targeted deletion of T-cell S1P receptor 1 ameliorates cardiac fibrosis in streptozotocin-induced diabetic mice, The FASEB Journal, October 2018, Federation of American Societies For Experimental Biology (FASEB),
DOI: 10.1096/fj.201800231r.
You can read the full text:

Read

Contributors

The following have contributed to this page